Osteoporotic fracture, diagnostic activity, and treatment in patients with gout.
Gout patients had higher nonvertebral osteoporotic fracture rates than osteoarthritis patients
Osteoporotic fracture, diagnostic activity, and treatment in patients with gout.
With gout may be at high risk for developing osteoporosis and osteoporotic fractures, but osteoporosis may be under-recognized and inadequately managed for patients with gout.
We aimed to describe osteoporotic fractures and diagnosis, DXA utilization, and bone protective therapy patterns in patients with gout and comparator groups.
We conducted a retrospective cohort study using the ACR RISE registry linked to Medicare claims (2015-2021), with 1:1 exact matching (age ±2 years, sex, race, enrollment quarter) to osteoarthritis (osteoarthritis) and soft tissue rheumatism (soft tissue rheumatism) comparator patients.
gout patients had higher nonvertebral fracture rates than osteoarthritis patients
Only five percent of patients with gout used bone protective therapy at baseline, compared to 11.8% in osteoarthritis.
2.6% and 15.4% in osteoarthritis patients.
Approximately 9.0% of patients with gout and 23.2% with soft tissue rheumatism used bone protective therapy at baseline.
30.7% in soft tissue rheumatism.
Patients with gout experienced greater rates of osteoporotic fracture and greater osteoporotic fracture risk factors (e.g.
chronic kidney disease, greater glucocorticoid use) compared to osteoarthritis and soft tissue rheumatism patients yet were less likely to receive bone protective therapies.